Although no difference of prognosis between diffuse‐type and intestinal‐type gastric cancer was found in the p53 no‐aberration group, intestinal‐type gastric cancer showed poorer prognosis than diffuse‐type cancer in the p53 aberration group46 (Figure 3A). This evidence concerns the gene TP53 and gastric cancer.